Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
HeartBeam, Inc. entered into SPA with Maverick Capital Partners, LLC valued at up to $5,000,000 (effective 2023-02-28).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- Maverick Capital Partners, LLC
- Value
- up to $5,000,000
- Effective
- 2023-02-28
Exact text from the filing
On February 28, 2023, HeartBeam, Inc. (the “Company”) entered into a securities purchase agreement (the “SPA”) with Maverick Capital Partners, LLC (the “Investor”). Pursuant to the terms of the SPA, the Company agreed to sell, up to $5,000,000 (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) at 75% of the average calculated Volume Weighted Average Price (“VWAP”) per share during a Drawdown Pricing Period (as defined in the SPA).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
HeartBeam, Inc. entered into NPA with Maverick Capital Partners, LLC valued at up to $5,000,000 (effective 2023-02-28).
- Action
- entry
- Agreement
- notes offering
- Counterparty
- Maverick Capital Partners, LLC
- Value
- up to $5,000,000
- Effective
- 2023-02-28
Exact text from the filing
Additionally, in connection with the SPA, on February 28, 2023, the Company entered into a note purchase agreement (the “NPA”) with the Investor. Pursuant to the terms of the NPA, the Company agreed to sell, up to $5,000,000 principal amount of notes of the Company, bearing interest at 6% per annum (the “Convertible Notes”).
View on SEC.gov